RNVA - Rennova Health

| Exchange: NASDAQ

Sell Candidate
Thu 21'st Sep 2017

PERIOD 2017-06-22 - 2017-09-21
CHANGE -3.91%
PRICE $0.21
VOLUME
Buy
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy

BOLLINGER
Sell
Request Prediction
0.00%
Predict

Rennova Health Stock Analysis

Technical stock analysis for Thu 21'st Sep 2017

Sell candidate since 2017-09-20 Loss -3.91%

Rennova Health fell by -3.91% in the last day from $0.22 to $0.21 and has now fallen 5 days in a row. The price has fallen in 8 of the last 10 days and is down by -13.68% for this period. Volume has increased in the last day by 107 957 shares, but on falling prices. This is may be an early warning and the risk will be increased slightly for the next couple of days. In total, 714 978 shares bought and sold for approximately $151 146.

Trend

Rennova Health lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -41.65% during the next 3 months and, with 90% probability hold a price between $0.10 and $0.15 at the end of this period.

Signals

There are few to none technical positive signals at the moment. Rennova Health holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.23 and $0.26. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday September 13, 2017, which indicates further falls until a new bottom pivot has been found. Rennova Health gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 20 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Support & Resistance

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days. On the upside the stock meets some resistance from accumulated volume at $0.24, $0.25 and $0.26.

Price: $0.2114 Resistance: $0.24
Price: $0.2114 R: $0.24

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.02 between high and low, or 11.50%. For the last week, the stock has had a daily average volatility of 8.19%.

Rennova Health is oversold on RSI14 (20). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Overall risk:

           

Evaluation

Rennova Health holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.

Sell Candidate

Trade RNVA CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service. Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Help StockInvest improve by answering this short survey clicking HERE.

Build Your Watchlist

Add RNVA My Watchlist

Recommended
books of the week

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Sign up to get FREE access to awesome features

Auto-portfolios that gain up to 30%

Request predictions from other users

Watchlist builder with notifications

News updates from 100+ financial publications

START FREE 5-DAY TRIAL
START FREE 5-DAY TRIAL